SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007851
Filing Date
2022-05-09
Accepted
2022-05-09 16:35:16
Documents
87
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ymab-20220331x10q.htm   iXBRL 10-Q 1877708
2 EX-10.7 ymab-20220331xex10d7.htm EX-10.7 27875
3 EX-10.8 ymab-20220331xex10d8.htm EX-10.8 81288
4 EX-10.9 ymab-20220331xex10d9.htm EX-10.9 39626
5 EX-10.10 ymab-20220331xex10d10.htm EX-10.10 78162
6 EX-10.11 ymab-20220331xex10d11.htm EX-10.11 32091
7 EX-31.1 ymab-20220331xex31d1.htm EX-31.1 15695
8 EX-31.2 ymab-20220331xex31d2.htm EX-31.2 15545
9 EX-32.1 ymab-20220331xex32d1.htm EX-32.1 7837
10 EX-32.2 ymab-20220331xex32d2.htm EX-32.2 7715
  Complete submission text file 0001558370-22-007851.txt   7550028

Data Files

Seq Description Document Type Size
11 EX-101.SCH ymab-20220331.xsd EX-101.SCH 58946
12 EX-101.CAL ymab-20220331_cal.xml EX-101.CAL 48701
13 EX-101.DEF ymab-20220331_def.xml EX-101.DEF 202408
14 EX-101.LAB ymab-20220331_lab.xml EX-101.LAB 490644
15 EX-101.PRE ymab-20220331_pre.xml EX-101.PRE 375851
81 EXTRACTED XBRL INSTANCE DOCUMENT ymab-20220331x10q_htm.xml XML 1094269
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38650 | Film No.: 22905632
SIC: 2834 Pharmaceutical Preparations